Drugs / Euphorbia kansui
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04503928 | Aug 2020 → Aug 2022 | HIV infectious disease | Shanghai Public Health Clinical Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Euphorbia kansui | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04503928 ↗ |
| Action | Activate | “it could effectively induce ex vivo latent HIV-1 expression” NCT04503928 ↗ |
| Route | Oral | “1 g (10 pills) of Euphorbia kansui Pill taken by mouth” NCT04503928 ↗ |